Home / Immunology
Immunology
| 4 min read
In vivo CAR T, lab-grown eggs, trial access, postpartum depression, and RNA therapy for hereditary angioedema led drug discovery this week.
| 2 min read
New data suggests icotrokinra could challenge injectables with once-daily targeted peptide.
They don’t play by the rules, but the immune system wouldn’t work without them.
| 3 min read
Largest molecular analysis to date reveals more than 100 blood biomarkers tied to the disease.
| 4 min read
Big-ticket licensing, FDA shake-ups, and Alzheimer’s data led the news this week.
| 8 min read
By starting with T cells from healthy donors, Allogene is manufacturing off-the-shelf CAR T cell therapies that patients don’t have to wait for.
| 4 min read
Metabolic conditioning is emerging as a powerful strategy to enhance the potency, persistence, and manufacturability of next-generation cell therapies, providing new hope for hard to treat cancers.
Available on Demand
Discover a high-throughput, high-resolution approach to biologics stability screening that eliminates bottlenecks in formulation development.
| 4 min read
Data-led engineering and platform strategies are transforming T cell engagers into scalable, clinically viable cancer therapies.
| 4 min read
FDA rejections and safety concerns, a once-monthly HIV PrEP pill, developments in neuroscience drug development, and more led the news this week.
| 5 min read
Explore how the gut microbiome impacts health. Learn about a new study that reveals how a specific microbe, P. faecium, may help fight obesity.
| 9 min read
With new insight into IgE biology, a new, two-pronged strategy for eliminating the pathogenic immune cells that lead to allergies emerges.
